Corbus Pharmaceuticals (NASDAQ:CRBP) Receives Outperform Rating from Wedbush
Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Wedbush in a note issued to investors on Wednesday,RTT News reports. They presently have a $51.00 target price on the biopharmaceutical company’s stock. Several other equities analysts have also weighed in on the company. StockNews.com upgraded Corbus Pharmaceuticals […]
Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Wedbush in a note issued to investors on Wednesday,RTT News reports. They presently have a $51.00 target price on the biopharmaceutical company’s stock. Several other equities analysts have also weighed in on the company. StockNews.com upgraded Corbus Pharmaceuticals […]
